Monitor the effective date of the registration statement and subsequent selling activity by the selling stockholders, particularly 3i, LP (759,384 shares), Nomis Bay Ltd (588,144 shares), and BPY Limited (360,476 shares). The company's going concern qualification and frequent capital raises suggest continued cash burn and potential need for further financing.
Price Chart
Executive Summary
SeaStar Medical filed an S-3 resale registration statement covering up to 1,767,784 shares of common stock issuable upon exercise of warrants issued in an October 2, 2026 private placement. The company will not receive any proceeds from the resale of shares by selling stockholders, but could receive up to approximately $6.5 million if all warrants are exercised for cash. The filing follows a warrant exchange that generated $3.3 million in gross proceeds for the company, and the auditor's report includes a going concern qualification.
Key Financial Metrics
Key Facts
- S-3 registers resale of up to 1,767,784 shares by selling stockholders, representing 33.2% of current outstanding shares (5,315,967).
- Shares are issuable upon exercise of Series A warrants ($3.616/share, 5-year term), Series B warrants ($3.616/share, 18-month term), and placement agent warrants ($4.8325/share, 5-year term).
- Company will not receive proceeds from resales; could receive up to ~$6.5 million if all warrants are cash-exercised.
- On October 2, 2026, prior warrant holders exercised for cash at $3.866/share, generating ~$3.3 million gross proceeds, and received the new warrants.
- As of October 19, 2026, there were 5,315,967 shares outstanding; pro forma shares outstanding would be 7,083,751 if all warrants are exercised.
- Market cap is $13M; the maximum aggregate offering price for the resale shares is $4,754,455 (based on a $2.6895 reference price).
- The auditor's report on the 2025 financial statements includes an explanatory paragraph about substantial doubt regarding the company's ability to continue as a going concern.
- The company has 19 offering/registration filings in the last 24 months, indicating frequent capital raising.
Financial Impact
Potential dilution of up to 33.2% of current shares outstanding if all warrants are exercised and resold; potential cash inflow of up to $6.5 million to the company if warrants are cash-exercised.
Risk Factors
- Significant potential dilution of 33.2% from the resale shares, which could pressure the stock price.
- Going concern qualification in the auditor's report indicates substantial doubt about the company's ability to continue operating.
- High frequency of capital raises (19 offerings in 24 months) suggests ongoing cash needs and potential for further dilution.
- Warrant exercise prices ($3.616 and $4.8325) are above the recent stock price of $2.31, making cash exercise unlikely unless the stock appreciates significantly.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (Primary) | 0001213900-26-114387 |
| Document: ea030984501ex-fee.htm | 0001213900-26-114387 |
| Document: ea030984501ex5-1.htm | 0001213900-26-114387 |
| Document: ea030984501ex23-1.htm | 0001213900-26-114387 |
| Document: 0001213900-26-114387-index-headers.html | 0001213900-26-114387 |
| Document: 0001213900-26-114387-index.html | 0001213900-26-114387 |
| Document: 0001213900-26-114387.txt | 0001213900-26-114387 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 30, 2026 2d ago | S-3 | $2.30 | awaiting T+5 | awaiting T+5 | $2.24 (+2.61%) |
Oct 5, 2026 27d ago | 8-K | $3.19 $3.59 | ▼ −12.54% | ▼ −12.68% | $2.24 (+29.78%) |
May 6, 2026 25w ago | Press Release | $4.87 $4.84 | ▼ −0.62% | ▼ −1.75% | $2.24 (−54.00%) |
Mar 25, 2026 31w ago | Press Release | $2.79 $4.31 | ▲ +54.48% | ▲ +52.85% | $2.24 (−19.71%) |
Mar 18, 2026 32w ago | Press Release | $2.27 $2.79 | ▲ +22.91% | ▲ +25.12% | $2.24 (−1.32%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers